Situation normale

APOTHEEK CERESA-VAN BOSSTRAETEN
 SRL

3800 Sint-Truiden
Since 13/05/2004
BE0865301762
Financial Health Indicator
8
Equity
€64.5K
Gross Operating Margin
€199.9K
+11% YoY
EBITDA
€85.6K
+41% YoY
Gain/Loss
€69.8K
+4% YoY
Employees
1

Detailed insights into APOTHEEK CERESA-VAN BOSSTRAETEN’s financial history

See financial trends including, equity, operating income, profit/loss and employees of APOTHEEK CERESA-VAN BOSSTRAETEN. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2023 2022 2021 2020 2019
Equity
64.5K
64.5K
64.5K
64.5K
64.2K
Gross Operating Margin
199.9K
180.7K
189.1K
174.6K
227.7K
Gain/Loss
69.8K
66.8K
50.7K
66.4K
113.2K
Employees
1
1
1.5
1.9
2

Frequently asked questions about APOTHEEK CERESA-VAN BOSSTRAETEN

  • Where is APOTHEEK CERESA-VAN BOSSTRAETEN located?

    APOTHEEK CERESA-VAN BOSSTRAETEN’s headquarters is located in Luikerstraat 40 , 3800 Sint-Truiden.
  • When was APOTHEEK CERESA-VAN BOSSTRAETEN founded?

    APOTHEEK CERESA-VAN BOSSTRAETEN was founded in 2004-05-13. APOTHEEK CERESA-VAN BOSSTRAETEN has been active for 21 years.
  • What are APOTHEEK CERESA-VAN BOSSTRAETEN’s NACEBEL codes?

    APOTHEEK CERESA-VAN BOSSTRAETEN’s NACEBEL codes are
    • 47730 Commerce de produits pharmaceutiques (2025)
    • 52310 Pharmacies (2003)
    • 47730 Commerce de détail de produits pharmaceutiques en magasin spécialisé (2008)
  • What is APOTHEEK CERESA-VAN BOSSTRAETEN’s VAT number?

    APOTHEEK CERESA-VAN BOSSTRAETEN’s VAT number is BE0865301762.
  • What is APOTHEEK CERESA-VAN BOSSTRAETEN’s juridical form?

    APOTHEEK CERESA-VAN BOSSTRAETEN’s juridical type is Société à responsabilité limitée (SRL).
  • How many employees does APOTHEEK CERESA-VAN BOSSTRAETEN have?

    APOTHEEK CERESA-VAN BOSSTRAETEN has 1 employee.
  • How is the financial situation of APOTHEEK CERESA-VAN BOSSTRAETEN?

    openthebox has estimated that APOTHEEK CERESA-VAN BOSSTRAETEN’s financial health score to be 8/10.